Podcasts about aobiome

Dr Linda Stein Gold and Dr Jonathan Silverberg discuss the epidemiology, clinical presentation, and classification of atopic dermatitis of the hand and feet as well the as quantifying the multidimensional burden it has on patients' quality of life in clinical practice. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer:  This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Dr Jonathan Silverberg: Honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena Therapeutics, Amgen, AOBiome, Apollo Pharma, Arcutis, Arena Pharmaceuticals, Asana, ASLAN Pharmaceuticals, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GSK, Incyte, Invea, Kiniksa, LEO Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, Target RWE, Teva, UNION, and UpToDate. Speaker for AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi-Genzyme. Institution received grants from Galderma, Incyte, and Pfizer. Dr Linda Stein Gold: Investigator/advisor and/or speaker for AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi. © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2400314 - 1.0 - 06/2024  MAT-US-2405589 v1.0 - P Exp Date: 06/04/2026

Dr Linda Stein Gold and Dr Jonathan Silverberg discuss the challenges associated with diagnosis of atopic dermatitis of the hands and feet and how disease severity can be assessed in clinical practice. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer:  This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: Dr Jonathan Silverberg: Honoraria as a consultant and/or advisory board member for AbbVie, Alamar, Aldena Therapeutics, Amgen, AOBiome, Apollo Pharma, Arcutis, Arena Pharmaceuticals, Asana, ASLAN Pharmaceuticals, Attovia, BiomX, Biosion, Bodewell, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celgene, Connect Biopharma, CorEvitas, Dermavant, FIDE, Galderma, GSK, Incyte, Invea, Kiniksa, LEO Pharma, Lilly, Merck, MyOr Diagnostics, Nektar, Novartis, Optum, Pfizer, RAPT Therapeutics, Recludix, Regeneron, Sandoz, Sanofi-Genzyme, Shaperon, Target RWE, Teva, UNION, and UpToDate. Speaker for AbbVie, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi-Genzyme. Institution received grants from Galderma, Incyte, and Pfizer. Dr Linda Stein Gold: Investigator/advisor and/or speaker for AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi. © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2402602- 1.0 - 05/2024 MAT-US-2405594 v1.0 - P Exp Date: 06/04/2026

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SVX865. CME/MOC/AAPA credit will be available until March 7, 2025.Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders and the Rationale for Targeted Biologic Therapy: Focus on Moderate to Severe Atopic Dermatitis, Prurigo Nodularis, Chronic Urticaria, and Bullous Pemphigoid In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerAdam Friedman, MD, FAAD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Arcutis Biotherapeutics, Inc.; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Grant/Research Support from Incyte and Janssen Pharmaceuticals, Inc.Speaker for Bristol Myers Squibb; Incyte; Janssen Pharmaceuticals, Inc.; and Regeneron Pharmaceuticals Inc./Sanofi.Co-Chair/PlannerShawn Kwatra, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Amgen Inc.; Arcutis Biotherapeutics, Inc.; Asian Pharmaceuticals Pvt. Ltd.; Bristol Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Celldex Therapeutics; Dermavant Sciences, Inc.; Galderma; Genzada Pharmaceuticals USA, Inc.; Incyte; Johnson & Johnson Services, Inc.; LEO Pharma A/S; Novartis Pharmaceuticals Corporation; Pfizer; Regeneron Pharmaceuticals Inc.; and Sanofi.Grant/Research Support from Galderma; Incyte; Pfizer; and Sanofi.Co-Chair/PlannerPeter A. Lio, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Almirall, S.A.; Amyris, Inc.; AOBiome; ASLAN Pharmaceuticals Pte Ltd; Bristol Myers Squibb; Burt's Bees Products Company; Concerto Biosciences; Dermavant Sciences, Inc.; Galderma S.A.; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Merck & Co., Inc.; Micreos B.V.; MyOR; Pfizer; Pierre Fabre group; Regeneron Pharmaceuticals Inc./Sanofi Genzyme; Theraplex; UCB, Inc.; and Verrica Pharmaceuticals.Grant/Research Support from AbbVie Inc. and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Speakers Bureau participant with AbbVie Inc.; Galderma S.A.; Incyte; Leo Pharma Inc.; Lilly; L'Oréal USA, Inc.; Pfizer; and Regeneron Pharmaceuticals Inc./Sanofi Genzyme.Co-Chair/PlannerProfessor Dedee Murrell has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amryt Pharma plc; Castle Creek Biosciences, Inc.; Krystal Biotech; and RHEACELL GmbH & Co. KG.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

In today's episode we had the opportunity to interview Larry Weiss, MD who is the founder and CEO of Symbiome and Weiss Bioscience, Inc., a San Francisco-based microbiome research and development company. Prior to this he was the Founding Chief Medical Officer at AOBiome, and before that he was the founder and CSO of CleanWell Company. Dr. Weiss has an MD from Stanford University and a BS in Biochemistry from Cornell University. He has an extensive background in natural products chemistry, microbiology, clinical medicine, biophysics, pharmaceutical, and skin care product development. Join us in today's episode as we talk about the skin microbiome, postbiotics in skincare, a unique postbiotic skincare company called Symbiome, and what the future of skincare looks like. Listen to the episode on Apple Podcasts, Spotify, Google Podcasts, Stitcher, TuneIn, or on your favorite podcast platform. Topics Covered: What is the skin microbiome How does an imbalanced skin microbiome affect our skin What are postbiotics How does Symbiome differ from other postbiotic skincare companies What the future of skincare looks like Connect With Us: Check out the Symbiome collection here (we're loving The Renewal daily cleanser and The Answer reparative serum) Connect with Dr. Weiss on LinkedIn and Instagram Connect with Dr. Bryant Esquejo on Instagram, Youtube, and TikTok Interested in becoming a patient in Los Angeles? Schedule an appointment online here! Visit Dr. Bryant's website: http://www.drbryantesquejo.com Connect with Dr. Marilyn Merola on Instagram and TikTok Interested in an aesthetic treatment in San Diego? Schedule a free 15-min phone consultation online here! Struggling with adult acne? Check out Dr. Merola's holistic acne course Glow From Within here. Use code “HOLISTICBEAUTY10” for 10% off! Visit Dr. Merola's website: https://lucerenaturalmedicine.com Follow the Holistic Beauty Podcast on Instagram. Questions or topic requests for the podcast? Send an email to holisticbeautypodcast@gmail.com.

A good leader sets the tone for an organization. Without good leadership, employees won't know the right direction to take or what they can improve upon. While men and women may generally have different needs and motivations, the qualities that make a good leader are the same for both. What is also important and needed for all leaders to succeed is to continuously seek out next level mentors with fresh perspective so they don't get caught up in their own echo chamber and get left behind. Dr. Annalisa Jenkins, M.B.B.S., F.R.C.P. is a biopharma thought leader and a board member for several growing companies. She shares with us her experiences, from the British military to the boardroom, and what it's been like to work in this age of life science innovation and digital advances. Coming from a generation where male mentors were common, Dr. Jenkins speaks about working as a woman in her industry and how she's learned to be a “tough but fair” leader under their direction. Her broad array of experiences in health sciences shows us how to bring vision to our workplace as leaders. Visit https://www.iambeyondbarriers.com where you will find show notes and links to all the resources in this episode, including the best way to get in touch with Annalisa. Highlights:  [02:27] Annalisa's global background [05:09] Annalisa's career goals [08:08] What five things make a successful leader [13:35] Is there a difference between male and female leaders? [16:08] Other important qualities of a leader in the workplace [19:52] Identifying potential leadership mentors [29:21] Coping with division created by making decisions [35:19] The importance of feedback and not taking it personally  [42:38] Working in the age of life science innovation and digital age  [46:56] Identifying the waves that affect your industry [50:51] What book has greatly influenced Annalisa? [51:47] Annalisa's favorite quote [52:50] Annalisa's moniker to describe herself [53:19] One habit that makes a big difference in Annalisa's life [55:00] Annalisa's power song [56:41] How to connect with Annalisa Quotes: “Great leaders have a clarity of vision.” –  Dr. Annalisa Jenkins “People that can bring teams together and get them to collaborate are always going to be successful.” –  Dr. Annalisa Jenkins “Great leadership comes from those who are willing to lean in and take decisions.” – Dr. Annalisa Jenkins Lightning Round Questions: What book has greatly influenced you?  Who Says Elephants Can't Dance? By Louis V. Gerstner, Jr. What is your favorite inspiring quote or saying?  “Live the life you love and love the life you live.” What is one word or moniker you would use to describe yourself?  Gracious What is one change you've implanted that made your life better?  Carving out two hours every morning to go to the gym. To think, reflect, prepare myself. It creates mindfulness. What power song would you want playing as you walk out onto a stage?    “Paradise” by Coldplay, the song and video. About Dr. Annalisa Jenkins: Annalisa Jenkins, M.B.B.S., F.R.C.P. is a biopharma thought leader with over 25 years of industry experience. Dr. Jenkins has extensive recent experience in building and financing biotech companies pursuing cures for the most challenging rare diseases to address important medical issues globally. She has consistently built and led teams advancing programs from scientific research through clinical development, regulatory approval, and into healthcare systems around the world. In addition, she is an advocate for diversity and inclusion, particularly for women in science. Dr. Jenkins served as president and CEO of Dimension Therapeutics a leading gene therapy company that she took public on the NASDAQ and subsequently sold to Ultragenyx. Prior senior leadership roles have included the head of global research and development at Merck Serono Pharmaceuticals from 2013 to 2014, where she also served as executive vice president global development and medical from 2011 to 2013 and several leadership roles at Bristol Myers-Squibb (BMS) from 1997 to 2011, most recently serving as senior vice president and head of global medical affairs. Earlier in her career, Dr. Jenkins was a medical officer in the British Royal Navy during the Gulf Conflict, achieving the rank of surgeon lieutenant commander. Dr. Jenkins graduated with a degree in medicine from St. Bartholomew's Hospital in the University of London and subsequently trained in cardiovascular medicine in the U.K. National Health Service.  Dr. Jenkins is a board member of several growing companies, including Oncimmune, AVROBIO, COMPASS Pathways, AOBiome, AgeX, Phaim Pharma, Conduit Connect, Affimed, Genomics England, Blue Advent Ltd, Cocoon Biotech Inc. (Non-Executive Chair), and Kuur Therapeutics (Non-Executive Chair). She also is a medical trustee for the British Heart Foundation and a committee member of the Science Board to the U.S. Food & Drug Administration, which advises FDA leadership on complex scientific and technical issues, board member at Faster Cures a center of The Milken Institute and Chair of The Court of The London School of Hygiene and Tropical Medicine.  Additional appointments reflect Dr. Jenkins' commitment to advancing the opportunities of women in science and the need for new models of health care in resource poor settings. She serves on the boards of Women in Bio, an organization promoting careers, leadership, and entrepreneurship for women in the life sciences, and the Center for Talent Innovation (U.K.), dedicated to driving ground-breaking research that leverages talent across gender, generation, geography, and culture. She also is an executive committee member of Springboard Enterprises, and is on the Advisory Panel of the Healthcare Businesswomen's Association, which elected Dr. Jenkins as Woman of the Year in 2014. She co-founded and serves on the board of directors of YouBelong, a UK based charity developing and delivering new models of care to people currently living with mental health diseases and incarcerated in institutions in sub Saharan Africa.  Links: Websites: LinkedIn: https://www.linkedin.com/in/annalisajenkins/ Instagram: https://www.instagram.com/jenkinsannalisa

Kriben Govender (Honours Degree in Food Science and Technology) and James Shadrach (Honours Degree in Psychology) chat with The President of Skincare company Mother Dirt on the Skin Microbiome, factors impacting the development of skin disorders and fostering a healthy skin ecosystem by reintroducing naturally occurring soil bacteria.   Bio:   Jasmina Aganovic is the President of Mother Dirt, a line of biome-friendly personal care products focused on restoring and maintaining the delicate balance of the skin biome. The technology is based off research from AOBiome, a biotech company focused on transforming human health through products that restore Ammonia-Oxidizing Bacteria (AOB), which current hygiene practices have stripped from the modern microbiome. She is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT. Her career path combined her technical background with roles at consumer brands like LVMH, Fresh, NutraClick and Living Proof.         Topics discussed:   The Mother Dirt Origin Story- Meeting David Whitlock & Jamie Heywood Rolling in the dirt Ammonia Oxidising Bacteria The importance of nature The skin microbiome Acne, Eczema and Skin Inflammatory Disease The Skin Microbiome- Eyes and Ears of the Immune System Jasmina’s 10 year acne struggle  “Less is more" The impact of Antibacterial Agents in Skincare Products What is P. acne?  Balancing the Skin Microbiome Has David Whitlock taken a shower? Do we need to use deodorant? Skin Peace Keeper- Ammonia Oxidising Bacteria- nitrosomonas eutropha   AO+  Mist function Using AO+ as a deodorant  Biome Friendly Skincare What are Skin Probiotics? Is diversity best for the Skin Microbiome? When is the best time to apply AO+ Mist Is AO+ Mist suitable for children Jasmina’s Skincare Routine Jasmina’s top skincare tip         Brought to you by:   Nourishme Organics- Gut Health Super Store- Shine from the Inside   Nourishme Organics- Gut Health Super Store- Shine from the Inside   Shop Mother Dirt- 10% off using code:  motherdirt   https://www.nourishmeorganics.com.au/collections/mother-dirt   Allele Microbiome- Microbiome Testing   Microbiome Stool testing (10% off Gut Explorer Pro using code: gutlove)    https://www.allele.com.au/collections/frontpage/products/gut-microbiome-analysis     Connect with Jasmina Aganovic   Website- https://motherdirt.com/             Connect with Kriben Govender:    Facebook- https://www.facebook.com/kribengee/ Instagram- https://www.instagram.com/kribengovender/ Youtube- https://www.youtube.com/c/Nourishmeorganics?sub_confirmation=1 Gut Health Gurus Facebook Group: https://www.facebook.com/groups/nourishmeorganics/ Mito Wellness Support Facebook Group: https://www.facebook.com/groups/347845406055631/   Download links                 If you enjoyed this episode and would like to show your support:   1) Please subscribe on Itunes and leave a positive review     Instructions:   - Click this link  https://itunes.apple.com/au/podcast/gut-health-gurus-podcast/id1433882512?mt=2   - Click "View in Itunes" button on the left hand side - This will open Itunes app - Click "Subscribe" button - Click on "Ratings and Reviews" tab - Click on "Write a Review" button   Non Itunes user’s can leave a Google Review here: http://bit.ly/nourishmeorganics     2) Subscribe, like and leave a positive comment on Youtube   https://www.youtube.com/c/Nourishmeorganics?sub_confirmation=1   3) Share your favourite episode on Facebook, Instagram, and Stories 4) Let your friends and family know about this Podcast by email, text, messenger etc   5) Support us on Patreon for as little as $5 per month and get same day, early access to our latest podcasts (typically around 4 to 6 weeks earlier than the general public) https://www.patreon.com/nourishmeorganics   Thank you so much for your support. It means the world to us.    

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Bayer, Monsanto, PPD, Medpace, AIFA, Eli Lilly, Pfizer, Genentech, AOBiome, Novartis, Iqvia, FDA, Cellply, PRA Health Science, Covance.Persone: Jesse Geiger (Medpace).Patologie: cancro.Lavoro: Clinical Team Manager, CRA II.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Bayer, Monsanto, PPD, Medpace, AIFA, Eli Lilly, Pfizer, Genentech, AOBiome, Novartis, Iqvia, FDA, Cellply, PRA Health Science, Covance.Persone: Jesse Geiger (Medpace).Patologie: cancro.Lavoro: Clinical Team Manager, CRA II.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

Click here for the show notes! Please leave us a review at http://openskyfitness.com/review   The Paleo Connection to Our Primal Health   "I don't see Paleo as an end point. I see it as the starting point on a launch pad. It's the beginning of something that works for a lot of people; especially for people who have digestive autoimmune conditions, people who have poorly explained conditions of any kind, or those who find it difficult to lose weight. If you reach a certain point in which you're happy with your health, you enjoy foods like dairy, you can digest it and it's a part of your life, then go enjoy it." - John Durant   On this week's episode of the Open Sky Fitness Podcast, we had author of New York Times Bestselling books, The Paleo Manifesto and Spartan Fit! (with Joe De Sana, CEO and Co - Founder of the Spartan Race), and Founder of Wild Ventures, John Durant join us. John, who calls himself a Professional Caveman, became interested in learning about our connection to our ancestors way back in high school. Throughout high school and college, he studied evolution psychology and even wrote about it in his senior thesis. Living by Our Ancestral History   "We don't really understand how well adapted we are to certain habitats until we leave them. Until we change it, screw it up, and lose something. Some of the lessons that we have learned about our habitat have come from going into very novel ones." - John Durant   After years of research, study, and experiments of both humans and animals like the gorilla, John shares the importance of living a Paleo lifestyle to the best of our ability and how our ancestral connects to our: Chronic health conditions Poor dieting decisions Hormones Personal habitat and lifestyle Plus, John goes into detail about how Wild Ventures is helping various health and wellness related start-ups get the investment they need to grow. Current companies include: Greatist Thrive Market Primal Kitchen Kettle & Fire At the beginning of the show, Devon and I also go over what the 7 Primal Movements are and why we should be incorporating them into our weekly workouts.   Building an Optimal Habitat and Life   "How do I build a life for myself where it doesn't require discipline to be healthy? It's just something that flows natural from who I am and who I interact with. You basically get to create your own world." - John Durant   To change our lifestyles, we need to have willpower, but very few people actually have that. When we want to make changes in our live, what disciplinary action can we take to change something in our habitat? It could be anything from changing the lights for better sleep or getting rid of extra junk food lying around the house. To create the life you want, make sure it includes the people that you want to be part of your habitat. Look for a community of people who want to grow and thrive as well. Join a gym or spend time with friends who also want to live healthy lives and improve their own habitats.   "We do the best that we can with the lives that we have today and the budgets that we follow." - John Durant on how we can make what changes we can to live a healthier lifestyle.   How to Hack Your Habitat: Living By Design, Not By Default (John Durant) https://www.youtube.com/watch?v=ttFSPYGFAco   Biohacking Our Internal Computers People are different and therefore one diet, exercise plan, or way of living is not a fit for everyone. We can actually biohack ourselves and do experiments to see what works and doesn't work for our individual bodies from nutrition to fitness. We all have different preferences, likes, dislikes, budgets and ways of living so it's normal that we're all doing different things to change our environment and get healthy in our own way. Going all the way back to our ancestors, our bodies are programmed the same way to send us signals in accordance to our environment. Depending on what we're eating or how much we're exercising, our bran and body use the ancestral software we've been programmed with to carry and send different messages. For example, for women who are constantly dieting or over exercising, the body believes that there's either a famine or a migration going on. When this happens, it's common that women won't have their period or they don't have enough resources to become pregnant because the the body is unable to provide enough resources for the support and growth of the baby.   The Benefits of Primal Movement When we're babies up until 2-3 years old, these primal movements come so easy to us. Then, we're stuck in desks at school or work for the rest of our lives. For optimal joint and body health, try to put these 7 primal movements into your daily workouts, if not a weekly basis when you're doing your workout program. If any of these movements do cause you to feel pain, it's either because you're doing them wrong or it's been so long since you've done them that your body just doesn't know how to do them anymore. These shouldn't cause you pain and you should be able to do them all. As you do these movements such as the lunge, you don't need to put a lot of pressure on your knees. If something is hurting, you should meet with a trainer or physical therapist so they can help you heal what's wrong with your body. The 7 Primal Movements Push Turn over or twist your spine throughout the body in a traverse movement Crawl Pull Hinge Squat Lunge   About John Durant John Durant is an author, entrepreneur, venture investor, and professional caveman. John is author of The Paleo Manifesto and co-author of Spartan Fit! with Joe De Sena, founder of Spartan Race (July 2016). He has been featured in the New York Times and The New Yorker, interviewed on The Colbert Report and NPR Morning Edition, and has been rated one of The 100 Most Influential People in Health & Fitness. John is also the founder of Wild Ventures, an angel syndicate specializing in consumer health products & technology. He advises Thrive Market, Exo, AOBiome, Greatist, Brilliant Bicycles, Hu Kitchen, and Power Supply. John studied evolutionary psychology at Harvard under Steven Pinker before moving to New York City and becoming a “professional caveman”: mimicking a hunter-gatherer diet, running barefoot through Central Park, experimenting with intermittent fasting, and doing polar bear swims in the Atlantic. Previously, he spent three and a half years at an ad tech startup after a stint in management consulting.   Thursday Night Live Q & A Sessions with Rob and Devon Each Thursday night at 7:15pm PST via the closed Open Sky Fitness Facebook Group , Devon and I will be online to answer an questions you may have about health, wellness, fitness, nutrition, lifestyle etc. Ask us anything!     Join The Open Sky Fitness Podcast Group! That's right! We have a closed Open Sky Fitness Podcast group  on Facebook where you and everyone have the opportunity to talk about your health and fitness goals in a safe environment. We post workouts and start discussions about how to be strategic around finding a healthier you. Check it out! Start Building Your Own Workouts and Meal Plan! Download Results Tracker here! Click To Download Home Workout Templates or text the word, "lifting," to 33444 to download the templates.  Download the OSF Food Journal Now! Have a Question or Review for Rob or Devon? We love answering questions and getting feedback from you, our listener! If you have any questions to ask us, want to share a review of the show, or tell us any suggestions for guests/topics that you think would be great to have on the show, just email Rob at rob@openskyfitness.com or Devon at devon@openskyfitness.com or you can also leave us a review at www.openskyfitness.com/review, ask a question in the closed Open Sky Fitness Facebook Group and even text OSFreview to 33444 to get the link.   What You'll Hear on This Episode 00:00 Open Sky Fitness Introduction 1:15  Opening comments with Rob and Devon 3:50  Recap on last week's episode OSF 157- Milk: Why Do We Even Need It? 4:15  About today's guest, John Durant, on the Paleo diet, religious rituals, and more 4:45  Grow with our online health and wellness community: OSF Facebook Podcast group! 5:10  Check out the Mind Pump podcast this week with Rob as their guest! 7:40 Contact Rob and Devon for One -on- One coaching 8:45  The 7 Primal Movements explained by Rob and Devon 22:00  The benefits of the 7 Primal Movements in your regular workout 25:00  Introduction to today's guest: John Durant 26:50  Why John decided to learn more about the Paleo lifestyle for academic reasons 30:00  Why chronic health conditions even exist with other species such as animals in zoos. 35:20  Why we're reducing our diets down to the constituent basics like a protein bar. What health effects gorillas in zoos experienced based on their diets. 39:00  Why we're being so misinformed by the mass media about health, fitness, and nutrition. 42:30  Hormones and weight gain 45:00  Changing our lifestyles to live healthier lives and the mistakes we've made along the way. 49:35  How we can create an optimal, healthy habitat for ourselves 51:40  How to avoid health mistakes like going for fast food over cooking dinner 54:00  The rise and fall of the Paleothic Age - Our ancestors' health 58:45  What was the spectrum for good teeth health for our ancestors'? What changed for us? 1:04:20  How we can answer any health question through The Paleo Manifesto? What can we learn from our ancestors? 1:08:00  How we can understand our bodies like a computer 1:11:50  Why we should avoid dogmatic approaches to health 1:15:40  About John's latest project with Wild Ventures and the companies he supports. 1:22:00 The benefits of bone broth 1:26:00  How big food chains are taking the nourishment out of the foods they sell like soup and broth companies. 1:28:40  How voting with your wallet and buying from healthy food companies and startups is making a huge difference. 1:34:25  Closing comments with Rob and Devon 1:36:50 Open Sky Fitness Closing   RESOURCES MENTIONED DURING THE SHOW: Leave us an iTunes review Join the The Open Sky Fitness Podcast Group on Facebook Contact Rob and Devon to apply for One-On-One Coaching Sessions Check out last week's episode -  OSF 157- Milk: Why Do We Even Need It? Visit John Durant's Hunter Gatherer Official Website Learn more about Wild Ventures: Thrive Market Kettle and Fire Primal Kitchen Connect with John via: Twitter Facebook Stay tuned for Rob's upcoming interview on the Mind Pump Podcast Buy your own Primal Kitchen Mayo Join the Spartan Race Find out more about the Spartan Race with Hunter McIntyre on OSF 099 - Evolution of a Spartan Athlete Listen to Josh Trent on OSF 077 - How to Stop Negative Thoughts Learn more about Michael Pollan Find out more about Dr. Daniel E.  Lieberman   Get Fit with Free Downloads! To Download Rob’s FREE workout templates click below** Download Templates Ask Rob a Question or tell him what is working for you: Email Rob@OpenSkyFitness.com   Support This Podcast To leave a Review for Rob and the Open Sky Fitness Podcast CLICK NOW!  Ratings and reviews are extremely helpful and greatly appreciated! They do matter in the rankings of the show and I read each and every one of them. Contact our amazing sound engineer Ryan? Send him an e-mail here: info@stellarsoundsstudio.com Thanks for Listening! Thanks so much for joining us again this week. Have some feedback you’d like to share? Leave a note in the comment section below! If you enjoyed this episode, please share it using the social media buttons you see at the bottom of the post. Do you have any questions (and would like to hear yourself on the Open Sky Fitness Podcast)? Click on the link on the right side of any page on our website that says “Send Voicemail.” And finally, don’t forget to subscribe to the show on iTunes to get automatic updates. It’s free! Thanks for listening/reading Episode 158 with John Durant: Biohack Your Health with Paleo! We hope you have gained more knowledge on how to be a healthier you.

This week’s Whole Life Challenge podcast guest is John Durant. John is the author of The Paleo Manifesto and co-author of Spartan Fit! by Joe De Sena, founder of Spartan Race (July 2016). He is also the founder of Wild Ventures, an angel syndicate focused on consumer health products & technology. He advises Thrive Market, Exo, AOBiome, Greatist, Brilliant Bicycles, Hu Kitchen, and Power Supply. John studied evolutionary psychology at Harvard under Steven Pinker before moving to New York City and becoming a "professional caveman": mimicking a hunter-gatherer diet, running barefoot through Central Park, experimenting with intermittent fasting, and doing polar bear swims in the Atlantic. He has been featured in the New York Times and The New Yorker, interviewed on The Colbert Report and NPR Morning Edition, and has been rated one of The 100 Most Influential People in Health & Fitness. Prior to becoming a professional caveman, he spent three and a half years at an ad tech startup after a stint in management consulting. [Note: For the complete set of show notes, links, and contact info, head to https://www.wholelifechallenge.com/podcast]

Jasmina Aganovic is a cosmetics and consumer goods entrepreneur who received her degree in chemical and biological engineering from MIT, and she’s back on the podcast to talk about the progress AOBiome have made with their clinical trials. In this interview, we focus mostly on the potential treatment of acne and hypertension, but trials are also underway for allergies, eczema, wound healing, migraines and temperature regulation. Mother Dirt is the company focussed on commercialising the research of AOBiome, and I’ve been using their AO+ Mist spray product for over two years for the successful prevention of nappy (diaper) rash, saddle sores, and acne caused by bike helmets. I’ve also been using the spray in the place of a deodorant, and so far my wife hasn’t divorced me. Jasmina wanted to make it clear that although my N=1 experiences are exciting, nothing has been FDA approved. Head over to Mother Dirt and take advantage of the generous 25% discount on offer. Use the code NBT25. Sign up for our Highlights email and every week we’ll send you a short (but sweet) email containing the following: One piece of simple, actionable advice to improve your health and performance, including the reference(s) to back it up. One item we read or saw in the health and fitness world recently that we would like to give a different perspective on, and why. One awesome thing that we think you’ll enjoy! Here’s the outline of this interview with Jasmina Aganovic: [00:03:43] Environmental changes are leading to the loss of the ammonia oxidising (AO) bacteria. [00:05:14] Nitrogen cycle. [00:07:18] David Whitlock is the Inventor and co-founder of AOBiome. [00:07:34] Why horses roll in the dirt in March? [00:08:36] The link between the skin and the soil. [00:09:36] Developing a bioreactor. [00:10:28] Nappy rash. [00:11:05] Bicycle helmets. [00:13:11] The scientific process to validate the claims. [00:13:55] Phase II trials for acne. [00:14:26] A potential replacement for antiperspirant deodorant. [00:14:50] Prevention of saddle sores. [00:15:36] The war on P. acne. [00:16:49] It's all about balance. [00:17:23] C. diff overgrowths. [00:18:49] Mechanism of action: acid, base balance. [00:19:44] Nitrite and Nitric oxide. [00:20:55] Not nitrous oxide! Which mucks up methylation by oxidising cobalamin. [00:21:52] Hypertension. [00:24:05] Highlights sign-up. [00:25:09] Can nitric oxide made by the bacteria on the skin become systemic? [00:26:47] Why FDA approval. [00:29:37] Adverse events. [00:30:47] Drug: B244 on clinicaltrials.gov. [00:31:16] Romaine Bardet came 2nd in the Tour de France. [00:32:28] Increasing O2 deliverability. [00:33:46] Personal care product compatibility. [00:34:11] Surfactant sodium octyl sulfate (SOS) and sodium dodecyl sulfate (SDS) surfactants. [00:35:13] Castille and neem soap. [00:36:11] Nurses and hand sanitisers. [00:37:59] http://www.nourishbalancethrive.com/dirt/ use discount code NBT25. [00:38:35] Mother Dirt is the consumer-facing site, to learn about the clinical research go to AOBiome.

Since an early age, Wang Jun has been fascinated with the fundamental philosophical question: What is life? The ex-CEO of Chinese genome sequencing giant BGI and founder of China's highest-valued precision health start-up iCarbonX now aims to help people answer that question for themselves. Wang entered Peking University, China's top university, at the age of 16 after achieving the highest college entrance exam score in his hometown of Dongtai county, in Jiangsu province. During the early 1990s, he pursued his interest in the fundamentals of intelligent life by studying artificial intelligence. In one experiment, he discovered that computers could actually figure out how a lady beetle maneuvers to catch food, exactly like it does in real life. Watch A Video As iCarbonX's Wang Jun Chats With China Money Network: But working at the dawn of the personalized computer era, it became clear to Wang that computers could not think like a human – at least not yet – with the kind of computer powers and digital data available back then. So Wang, born in 1976, turned his attention to another potential golden key to unlocking the secrets of life: Genomes. In 1999, after having studied artificial intelligence, computer science and biophysics, he participated in founding BGI, which represented China’s contribution to the US$3 billion Human Genome Project. While at BGI, Wang managed three rounds of fundraising of about US$1 billion and led the company's acquisition of a U.S. public company, Complete Genomics. He continued scientific research by participating in the effort to sequence and analyze the rice genome and the SARS (Severe Acute Respiratory Syndrome) virus. He left BGI in 2015 (though he remains a board member and shareholder) to start iCarbonX because he believes genes alone can't decode life. "If I eat more, I become fat. If I run marathons, the body reacts differently. But my genome remains the same," he said. iCarbonX’s goal is to help people understand and manage their lives better by combining genomics with every other health factor, including metabolites, bacteria and lifestyle choices, to create a digitalized form of life, an avatar or sorts, for everyone willing to pay at least US$30 for a basic product or much more for advanced solutions. "I can use this digitalized form of me to see how my body will react to a cup of coffee (or a drug or daily exercises), for example," he explained. To date, iCarbonX has invested US$400 million in seven companies to form a Digital Life Alliance, an information ecosystem designed to fulfill Wang's vision. Fives U.S. companies, SomaLogic, HealthTell, PatientsLikeMe, AOBiome, GALT, one Israeli company Imagu Vision and Chinese firm Tianjin Robustnique Corporation Ltd. each bring core technologies such as protein biomarker discovery, bacterial therapy and immunosignaturing to the alliance. iCarbonX is also launching its first product, a digital health management platform named Meum. It will provide different levels of life data and dozens of applications to users for better control of their well-being. With Chinese technology giant Tencent Holdongs Ltd. being iCarbonX's major investor, the company is also developing a product that will be available to over 800 million active users of Tencent's immensely popular Wechat app, Wang said. Wang's belief in the life-technology interface go beyond commercial concerns. He's convinced that a digitalized form of individuals could ultimately be able to live on in silicon form even after their carbon-based human bodies perish. He has declared such ambitions many times, openly and privately. It is too early to speculate on that, but there is at least one problem Wang faces trying to fulfill iCarbonX's commercial promise. The start-up achieved a US$1 billion valuation in a short six-months after being established, making it the fastest technology unicorn in the world.

Welcome to the Wealthy Wellthy Life with Krisstina Wise. David Whitlock hasn’t showered in 13 years — why? Because not all bacteria on your skin is bad for you. Sound a little crazy? Well, it isn’t. There’s a big difference between being ‘clean’ vs. being ‘sterile’. Through David’s company, AOBiome, he has developed a spray with ammonia-oxidizing bacteria (AOB) and sells it for commercial use under the name Mother Dirt. This is how he’s kept clean for all these years! Jasmina Aganovic is the President of Mother Dirt as well as the General Manager for Consumer Products at AOBiome. Jasmina and her team study the importance of good bacteria on the skin and its impact on our health. Through her research, Jasmina and David have come up with biome friendly products that do not kill the good bacteria on your skin. For full show notes and to download a FREE copy of the transcript for this episode visit http://wealthywellthy.life/31  

On this week's episode of The Microbiome Podcast we talked with Dr. Larry Weiss, Chief Medical Officer for AOBiome, about the skin microbiome and AOBiome's cosmetic product and their approach to treating skin diseases. We offered a 25% discount code (ami25) to listeners interested in purchasing thier cosmetic product and we discussed AMI's initiative to support Your Private Biome, a citizen science project focused on the vaginal and penile microbiome. Read detailed shownotes.

Art by Noa Kaplan. Photo by Jed Kim Your skin is your largest organ and is also is a thriving ecosystem, covered in bacteria. While many of us consider regular showers key to keeping our skin healthy, a group of scientists — and artists — are starting to ask: Could the future of skin care not be soap, but bacteria? Inside the Episode Biologist Christina Agapakis visits AOBiome in Cambridge, Mass. to talk with the team there that has developed a bacterial mist you spritz on your skin several times a day instead of showering. Then, it’s off to rethink one of the most common skin problems, pimples. We meet Noa Kaplan, who makes sculptures based from ultra-magnified shots of her pores. ©Noa Kaplan ©Noa Kaplan We also explore how fabric could support our skin’s ecosystem. Fashion futurist Suzanne Lee talks about the not-too-distant future when our clothes may do more than just cover us – they may be made from living bacteria and designed to interact with our skin. Check out this article about Suzanne’s process, and her TED Talk. This episode was produced by Kerry Donahue and Sruthi Pinnamaneni, and mixed by David Herman. Music credits: Hauschka: “Cube” from Salon des amateurs Four Tet: “As Serious As Your Life” from Rounds Anna Meredith: “Bubble Gun” from Jet Black Raider Pye Corner Audio: “Palais Spectres” from Sleep Games Laurie Spiegel: “Patchwork” from The Expanding Universe